RxDoctor Payments Data

Anitha Police, MD

Internal Medicine · Jacksonville, FLNPI 1821127903

Payments from drug & device makers

$6,722in general payments, 2019–2025

Across 396 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$759
  • AbbVie$435
  • GSK$419
  • Abbott$417
  • Boehringer Ingelheim$372
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$6,722100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,722 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$157,444
Medicare patients
358
Services billed
2,471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$112,446
EliquisApixaban61$65,190
MounjaroTirzepatide33$54,154
JardianceEmpagliflozin33$40,693
TrulicityDulaglutide34$35,849
GlyxambiEmpagliflozin/Linagliptin29$34,012
JanuviaSitagliptin Phosphate21$31,051
TradjentaLinagliptin22$28,145
MyrbetriqMirabegron18$19,434
Breo ElliptaFluticasone/Vilanterol24$13,523
SynthroidLevothyroxine Sodium110$10,361
Repatha SureclickEvolocumab13$8,557
Levothyroxine Sodium367$4,592
Rosuvastatin Calcium409$4,027
PaxlovidNirmatrelvir/Ritonavir28$2,797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,424$112,44689 claims
Boehringer IngelheimJardiance, Glyxambi, Tradjenta$372$102,85084 claims
Lilly USA, LLCMounjaro, Trulicity$759$90,00267 claims
PfizerEliquis, Paxlovid$222$67,98789 claims
MerckJanuvia$190$31,05121 claims
Astellas Pharma US IncMyrbetriq$224$19,43418 claims
GSKBreo Ellipta$419$13,52324 claims
AbbVieSynthroid$435$10,361110 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$4,592367 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →